<DOC>
	<DOCNO>NCT01930903</DOCNO>
	<brief_summary>The propose study demonstrate , whenever use Drug Eluting Stent possible , clinical security 12 month , combinaison Bare Metal Stent plus Drug Eluting Balloon .</brief_summary>
	<brief_title>PaneLux PTCA : Proposing Alternative Treatment patiEnts Whom DES Implantation Not Indicated , Thanks Pantera LUX Drug Eluting Balloon</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Subject provide write informed consent 2 . Subject &gt; /= 18 year . 3 . Patient affiliate social security 4 . Patient acceptable candidate accept contact different term clinical follow ( 1 , 6 12 month ) 5 . Subject eligible percutaneous coronary intervention AND undergoing chronical oral anticoagulant treatment OR undergoing semiurgent invasive non cardiac surgical plan intervention major bleed risk 6 . Subject eligible Dual Anti Platelet Therapy ( DAPT ) acetyl salicylic acid clopidogrel least 3 week 7 . De Novo coronary lesion : &gt; /= 50 % &lt; 100 % 8 . Subject , vessel target lesion eligible angioplasty PROKinetic Energy stent implantation final postdilatation Pantera Lux drug elute balloon . 9 . Target lesion length &lt; /= 26 mm , visual estimation Quantitative Coronary Angiography ( QCA ) 10 . Reference diameter target vessel &gt; /=2.5mm &lt; /= 4.0 mm ( visual estimation QCA ) 1 . Pregnant breast feeding female females intend become pregnant time study 2 . Subject life expectancy le 1 year 3 . Vulnerable subject , protect law , unable give his/her consent 4 . Subject currently enrol medical drug study reach primary outcome measure study 5 . Subject unable contact clinical follow 1 , 6 12 month 6 . Subject chronical oral anticoagulant treatment ( optionnal indication ) 7 . Subject undergoing urgent invasive surgical intervention major bleed risk , maintain dual antiplatelet therapy ( DAPT ) least 3 week 8 . In stent restenotic lesion 9 . Target lesion vessel nominal diameter &lt; 2.5 mm 10 . Target lesion locate supply arterial venous bypass graft 11 . Chronical Total occlusion ( CTO ) 12 . Angioplasty indication STEMI 13 . Patient sign cardiogenic shock 14 . Angioplasty antecedent stent implantation ( 12 month DES , 6 month BMS ) 15 . `` Staged procedure '' &gt; 8 day initial angioplasty 16 . Documented leave ventricular ejection fraction ( LVEF ) &lt; /= 30 % 17 . Target lesion require stent implantation device predilatation balloon ( include , restrict laser , cut balloon , directional coronary atherectomy , rotational atherectomy etcâ€¦ ) 18 . Known allergy acetylsalicylic acid , active agent Paclitaxel , Expicients like BHTC ( Butiriltrinhexyl citrate ) , CoCr , Silicon Carbide .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>PRO-Kinetic Energy BMS + Pantera Lux DEB combination</keyword>
</DOC>